dehydroepiandrosterone sulfate has been researched along with Cystadenocarcinoma, Serous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Morita, T; Nagasaka, T; Shibata, K; Suzuki, T | 1 |
Bennett, P; Blaakaer, J; Bock, J; Daugaard, S; Høgdall, CK; Hørding, U; Toftager-Larsen, K | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Cystadenocarcinoma, Serous
Article | Year |
---|---|
Cushing's syndrome due to ovarian serous adenocarcinoma secreting multiple endocrine substances: a case report and immunohistochemical analysis.
Topics: Adrenocorticotropic Hormone; Aged; alpha-Fetoproteins; Cushing Syndrome; Cystadenocarcinoma, Serous; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Immunohistochemistry; Neurophysins; Ovarian Neoplasms; Parathyroid Hormone; Protein Precursors; Vasopressins | 2003 |
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aging; Androstenedione; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Progesterone; Prognosis; Regression Analysis; Testosterone | 1993 |